Skip to Content

Join the 'Urea Cycle Disorders' group to help and get support from people like you.

Urea Cycle Disorders News

FDA Approves Ravicti for the Chronic Management of Some Urea Cycle Disorders

Posted 3 Feb 2013 by

February 1, 2013 – The U.S. Food and Drug Administration today approved Ravicti (glycerol phenylbutyrate) for the chronic management of some urea cycle disorders (UCDs) in patients ages 2 years and older. UCDs are genetic disorders that involve deficiencies of specific enzymes involved in the urea cycle, a series of biochemical steps normally required to remove ammonia from the blood. When ...

Ask a Question

Further Information

Related Condition Support Groups

Metabolic Disorder Including Congenital

Related Drug Support Groups

sodium phenylbutyrate, Buphenyl, glycerol phenylbutyrate, Ravicti